Rare mutation subgroups in melanoma and how to treat them
Influence of new immunotherapy checkpoint inhibitors in melanoma
The re-emergence of cancer vaccines
Melanoma immunotherapy updates in 2016: clinical trials, developments and new survival data
What to do with BRAF-mutant melanoma patients who have a poor prognosis?